No evidence of an exaggerated albuminuric response to physical exercise in non-diabetic siblings of type 1 diabetic patients with diabetic nephropathy

By Fagerudd J. A.   Riska M. K.   Pettersson-Fernholm K. J.   Groop P.-H.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 60, Iss. 6, 2000-11 ,pp. : 449-456

Informa Healthcare

Access to resources Recommend Favorite

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study

By Persson Frederik   Rossing Peter   Hovind Peter   Stehouwer Coen   Schalkwijk Casper   Tarnow Lise   Parving Hans-Henrik  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 8, 2008-01 ,pp. : 731-738

Informa Healthcare

Access to resources Recommend Favorite

Gender‐ and disease‐specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathy

By  

NEPHROLOGY, Vol. 20, Iss. 5, 2015-05 ,pp. : 368-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Could we predict asymptomatic cardiovascular autonomic neuropathy in type 1 diabetic patients attending out-patients clinics?

By Lacigová Silvie   Šafránek Petr   Čechurová Daniela   Krčma Michal   Víšek Jakub   Jankovec Zdeněk   Žourek Michal   Haladová Iva   Rušavý Zdeněk  

Wiener klinische Wochenschrift, Vol. 119, Iss. 9-10, 2007-06 ,pp. : 303-308

Springer Publishing Company

Access to resources Recommend Favorite

Urinary Neutrophil Gelatinase-Associated Lipocalin and Progression of Diabetic Nephropathy in Type 1 Diabetic Patients in a Four-Year Follow-Up Study

By  

Nephron Clin Pract, Vol. 118, Iss. 2, 2010-12 ,pp. : c130-c135

Karger

Access to resources Recommend Favorite